Ads
related to: bladder cancer surveillance schedule
Search results
Results From The WOW.Com Content Network
Bladder cancer is most common in wealthier regions of the world, where exposure to certain carcinogens is highest. It is also common in places where schistosome infection is common, such as North Africa. [56] Bladder cancer is much more common in men than women; around 1.1% of men and 0.27% of women develop bladder cancer. [2]
The bladder tumour antigen (BTA) test is used in the detection of bladder cancer.It works by detecting raised levels of complement factor Hârelated protein (CFHrp), which is produced by cancer cells, in urine.
Urothelial cancer, including cancer of the bladder, urethra, ureters and renal pelvis [ edit ] A Phase 2 clinical trial entitled First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma was first reported in 2015 [ 66 ] Thirty-six patients were treated with chemotherapy, adding ipilimumab after the second 21-day cycle.
A new study has identified a protein that helps drive bladder cancer by triggering the synthesis of cholesterol via mouse and cell models. Researchers found that a combination therapy of two drugs ...
SEER collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately 34.6% of the population of the United States. SEER coverage includes 30.0% of African Americans, 44% of Hispanics, 49.3% of American Indians and Alaska Natives, 57.5% of Asians, and 68.5% of Hawaiian/Pacific Islanders. [3]
The test commonly checks for infection, inflammatory disease of the urinary tract, cancer, or precancerous conditions. It can be part of a broader urinalysis . If a cancerous condition is detected, other tests and procedures are usually recommended to diagnose cancers, including bladder cancer , ureteral cancer and cancer of the urethra .
Ads
related to: bladder cancer surveillance schedule